ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,737, issued on July 22, was assigned to Lassen Therapeutics Inc. (San Diego).
"Anti-IL-18BP antibodies" was invented by Robert A. Horlick (San Diego), Helen Toni Jun (San Diego), Magdalena S. Willen (San Diego), Christine M. Chidester (San Diego), Mark G. Barrett (Wellesley, Mass.), David J. King (Encinitas, Calif.) and Deborah A. Witherden (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases."
The pa...